VentriPoint Diagnostics Ltd. VPT.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 49.27% | 37.53% | 36.29% | 22.50% | 11.60% |
| Total Depreciation and Amortization | 0.00% | -0.45% | -4.58% | -7.22% | -8.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -110.87% | -68.73% | -36.94% | -0.97% | 211.26% |
| Change in Net Operating Assets | -46.41% | -14.54% | 52.78% | 176.18% | 44.77% |
| Cash from Operations | 15.98% | 34.60% | 55.02% | 55.44% | 43.71% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -53.67% | -71.45% | -21.49% | -27.61% | 18.76% |
| Total Debt Repaid | -1.51% | -2.28% | 23.10% | 23.67% | 22.92% |
| Issuance of Common Stock | 29.48% | 35.21% | -44.61% | 212.17% | 3,113.30% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 81.34% | 85.43% | 22.11% | -91.91% | -256.40% |
| Cash from Financing | -8.94% | -40.75% | -31.84% | 9.46% | 128.71% |
| Foreign Exchange rate Adjustments | -661.11% | 150.43% | 135.76% | -2,133.33% | 114.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 214.71% | -345.56% | 98.69% | 97.63% | 97.74% |